Description
The aging of the population and continued advances in biotechnology drive the skin ulcer portion of the wound care industry, estimated at $3.3 billion globally. A lack of effective treatment options has heretofore added to the increased costs of skin ulcer treatment and has contributed to the growing frustration in the industry. New product manufacturers can capitalize on these concerns by offering products designed to improve healing rates and prevent wound formation within a cost-conscious framework.
Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. The use of hyperbaric oxygen therapy and electrical stimulation remain controversial, but opportunities for improved cost-effective outcomes are all welcome at this point.
New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes. Disease management programs that emphasize prevention and early intervention are resulting in the rapid adoption of new wound care products and devices, provided they have proven outcomes. This rapid uptake of new technology makes the chronic wound care market one of the best opportunities in medical device and biotechnology.
This study, the first volume in a complete re-examination of the wound care market, analyzes the market using the following product segments and subsegments:
- Anti-Infectives
- Skin Ulcer Management
- Compression Dressings and Bandages
- Wound Cleaners
- Debridement
- Moist Dressings
- Alginates
- Films
- Foams
- Hydrocolloids
- Hydrogels
- Biological Dressings
- Artificial Skin
- Collagen
- Growth Factors
- Others
- Pressure Relief
- Miscellaneous Treatments
The report details product offerings, research developments, industry trends, and relevant epidemiologic and demographic data. Market size, market growth, and market forecasts are provided for each segment and subsegment. Competitive market share information is provided by leading manufacturer for each segment in the year 2004.
The information and analysis presented in this report are based on an extensive survey of senior management in the wound care industry, specifically involved in treating skin ulcers. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals and company reports and releases. Key information from published literature was used to conduct interviews with over 30 industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Scope and Methodology
- Size and Growth of the Market
- Trends Affecting the Market
- Competitive Outlook
CHAPTER TWO: INTRODUCTION AND OVERVIEW
- Normal Integument
- Epidermis
- Dermis
- Subcutaneous Tissue
- Functions of Skin
- Effects of Aging on the Integumentary System
- Types of Wound Healing
- Defense Against Injury
- Mononuclear Phagocyte System
- Inflammatory Response
- Wound Healing Process
- Primary Intention
- Secondary Intention
- Tertiary Intention
- Dysfunction in Wound Healing
- Delayed Healing
- Complications of Wound Healing
- Hypertrophic Scars and Keloid Formation
- Contracture
- Dehiscence
- Excess Granulation Tissue
- Adhesions
CHAPTER THREE: SKIN ULCERS
- Pressure or Decubitus Ulcers
- Diabetic Ulcers or Neuropathic Ulcers
- Arterial Ulcers
- Venous Ulcers
CHAPTER FOUR: TREATMENTS
- Overview
- Anti-Infectives
- Products
- Market Segment Conclusion
- Skin Ulcer Management
- Products
- Compression Dressings
- Cleansing
- Debridement
- Market Segment Conclusion
- Moist Dressings
- Products
- Alginates
- Hydrocolloids
- Hydrogels
- Films
- Foams
- Market Segment Conclusion
- Biological Dressings
- Products
- Artificial Skin
- Collagen
- Growth Factors
- Other
- Market Segment Conclusion
- Pressure Relief Devices
- Products
- Market Segment Conclusion
- Miscellaneous Skin Ulcer Treatments
- Products
- Electrical Stimulation
- Electromagnetic Therapy Device
- Ultraviolet
- Oxygen and Hyperbaric Oxygen
- Mechanically Assisted Devices
- Warm-Up Therapy
- Silver Ion
- Whirlpool Therapy
- Ultrasound
- Low Intensity Laser Therapy
- Market Segment Conclusion
CHAPTER FIVE: MARKET SUMMARY
CHAPTER SIX: COMPETITIVE ANALYSIS
- Overview
- Competitive Market Summary
- Competitive Market Share by Segment
- Skin Ulcer Management
- Anti-Infectives
- Moist Dressings
- Pressure Relief Devices
- Biological Dressings
CHAPTER SEVEN: INDUSTRY DEVELOPMENTS
- Negligence-Based Lawsuits
- Pressure Ulcers and Quality of Care
- New Products
- Reimbursement
- Combination Treatments
- Psychosocial Factors in Wound Healing
- Mechanotransduction
- Hormones and Wound Healing
- Novel Treatments
- Products/Approaches in Development
- OrCel
- Thymosin Beta 4
- Lactoferrin
- Encelle E Matrix
- KGF-2
- BioFoam
- CoFoam Polyurethane Composite
- Allox
- CryoCeal
- LyphoDerm
- Other Innovative Products
- Addressing Unmet Need
- New Guidelines
- Wound Care Clinics
- Demographics, Incidence
CHAPTER EIGHT: COMPANY PROFILES
- Overview
- 3M Health Care
- Bertek Pharmaceuticals, Inc.
- Carrington Laboratories, Inc.
- ConvaTec, Ltd.
- Derma Sciences
- GlaxoSmithKline Plc
- Healthpoint, Ltd.
- Hill-Rom Company, Inc.
- Johnson & Johnson
- Kinetic Concepts, Inc.
- Pfizer, Inc
- Smith & Nephew, plc
APPENDIX: COMPANY DIRECTORY
L I S T O F E X H I B I T S
CHAPTER ONE: EXECUTIVE SUMMARY
- Figure 1-1: Worldwide Skin Ulcer Product Revenues by Segment 1999-2009
CHAPTER THREE: SKIN ULCERS
- Table 3-1: Common Sites for Pressure Ulcer Development
- Table 3-2: Stages of Pressure Ulcers
CHAPTER FOUR: TREATMENTS
- Table 4-1: Selected Topical Brand Name Anti-Infectives Currently Available (Product, Active Ingredient, Manufacturer)
- Table 4-2: Market for Anti-Infectives in the Treatment of Skin Ulcers 1999-2009
- Table 4-3: Selected Compression Dressings and Bandages Currently on the Market
- Table 4-4: Toxicity Index for Selected Wound Cleansers
- Table 4-5: Selected Cleansing Agents Currently on the Market
- Table 4-6: Selected Debridement Agents
- Table 4-7: Skin Ulcer Management Market Segment Summary Revenues by Segment (Cleansing, Debridement, Bandages & Dressings) 1999-2009
- Table 4-8: Selected Alginate Products Currently on the Market
- Table 4-9: Selected Hydrocolloid Products Currently on the Market
- Table 4-10: Selected Hydrogel Products Currently on the Market
- Table 4-11: Selected Films Currently on the Market
- Table 4-12: Selected Foam Manufacturers, Products and Cost
- Table 4-13: Skin Ulcers: Moist Dressing Market Segment Summary Revenues by Segment (Alginates, Hydrocolloids, Hydrogels, Films, Foams) 1999-2009
- Table 4-14: Selected Artificial Skin Products Currently on the Market
- Table 4-15: Selected Collagen Products Currently on the Market
- Table 4-16: Biological Dressings Market Segment Summary Revenues by Segment (Artificial Skins, Collagen, Growth Factors, Others) 1999-2009
- Table 4-17: Types of Mattresses – Advantages and Disadvantages
- Table 4-18: Selected Pressure Relief Equipment Currently Available
- Table 4-19: The Market for Pressure Relief Devices in Skin Ulcers 1999-2009
- Table 4-20: The Market for Miscellaneous Skin Ulcer Treatment 1999-2009
CHAPTER FIVE: MARKET SUMMARY
- Table 5-1: Skin Ulcers Revenues and Growth Rate by Segment 1997-2007
- Figure 5-1: Skin Ulcers Revenues by Segment 1999-2009
- Table 5-3: Skin Ulcers Share by Segment 1999-2009
- Figure 5-2: Skin Ulcers Market Share by Type 2004 vs 2009
CHAPTER SIX: COMPETITIVE ANALYSIS
- Table 6-1: Major Competitors and Primary Segments of Participation 2004
- Table 6-2: Revenues and Share of Total Skin Ulcer Market by Leading Supplier 2004
- Figure 6-1: Market Share by Leading Supplier 2004
- Table 6-3: Skin Ulcer Management: Revenues and Market Share by Leading Supplier 2004
- Table 6-4: Anti-Infectives: Revenues and Market Share by Leading Supplier 2004
- Table 6-5: Moist Dressings: Revenues and Market Share by Leading Supplier 2004
- Table 6-6: Pressure Relief Devices: Revenues and Market Share by Leading Supplier 2004
- Table 6-7: Biological Dressings: Revenues and Market Share by Leading Supplier 2004
CHAPTER SEVEN: INDUSTRY DEVELOPMENTS
- Table 7-1: Global and U.S. Population by Selected Characteristic, 1999, 2004, and 2009
- Figure 7-1: U.S. Population by Selected Age, 1999, 2004, and 2009
- Figure 7-2: Global Population by Selected Age, 1999, 2004, and 2009
- Table 7-2: Global and U.S. Yearly Incidence of Skin Ulcers by Type
- Figure 7-3: Global and U.S. Yearly Incidence of Skin Ulcers by Type
